We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
-4.54%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$130M
AUM Growth
+$26.6M
(+26%)
Cap. Flow
+$34M
Cap. Flow
% of AUM
26.04%
Top 10 Holdings %
Top 10 Hldgs %
9.96%
Holding
800
New
284
Increased
141
Reduced
77
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sensata Technologies
ST
|
+$1.38M |
| 2 |
Mastercard
MA
|
+$1.33M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.33M |
| 4 |
Abbott
ABT
|
+$1.31M |
| 5 |
Universal Health Services
UHS
|
+$1.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.17M |
| 2 |
Teradata
TDC
|
+$1.08M |
| 3 |
Phillips 66
PSX
|
+$1.05M |
| 4 |
Marathon Petroleum
MPC
|
+$1.05M |
| 5 |
Pentair
PNR
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.22% |
| 2 | Financials | 13.03% |
| 3 | Industrials | 12.41% |
| 4 | Technology | 11.95% |
| 5 | Healthcare | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRFT
176
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $265K | 0.2% |
+4,700
| New | +$272K |
|
|
RICE
177
DELISTED
Rice Energy Inc.
RICE
| $263K | 0.2% |
+9,900
| New | +$277K |
|
178
Air Products & Chemicals
APD
$65.5B
| $261K | 0.2% |
+2,171
| New | +$265K |
|
|
ICPT
179
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $260K | 0.2% |
1,100
+500
| +83% | +$127K |
|
180
Brookfield
BN
$102B
| $256K | 0.2% |
24,347
+23,066
| +1,801% | +$248K |
|
181
CVS Health
CVS
$135B
| $255K | 0.2% |
3,200
-8,300
| -72% | -$654K |
|
|
SC
182
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $253K | 0.19% |
+14,200
| New | +$268K |
|
|
ATVI
183
DELISTED
Activision Blizzard
ATVI
| $252K | 0.19% |
+12,143
| New | +$276K |
|
|
XL
184
DELISTED
XL Group Ltd.
XL
| $252K | 0.19% |
7,605
+2,000
| +36% | +$66.7K |
|
185
Banco Bradesco
BBD
$37.4B
| $252K | 0.19% |
45,156
+38,521
| +581% | +$241K |
|
186
Marriott International
MAR
$100B
| $252K | 0.19% |
+3,600
| New | +$244K |
|
|
NBIS
187
Nebius Group N.V.
NBIS
$37.6B
| $249K | 0.19% |
+8,965
| New | +$272K |
|
188
Xerox
XRX
$345M
| $249K | 0.19% |
+7,132
| New | +$249K |
|
|
STRZA
189
DELISTED
Starz - Series A
STRZA
| $248K | 0.19% |
+7,500
| New | +$225K |
|
190
L3Harris
LHX
$55.4B
| $246K | 0.19% |
3,700
+1,800
| +95% | +$127K |
|
|
SIAL
191
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $245K | 0.19% |
1,800
+1,000
| +125% | +$106K |
|
192
Boston Scientific
BSX
$68.4B
| $243K | 0.19% |
+20,617
| New | +$260K |
|
193
PepsiCo
PEP
$196B
| $242K | 0.19% |
+2,600
| New | +$237K |
|
194
KBR
KBR
$4.56B
| $241K | 0.18% |
+12,779
| New | +$277K |
|
|
FDO
195
DELISTED
FAMILY DOLLAR STORES
FDO
| $239K | 0.18% |
3,096
+2,700
| +682% | +$199K |
|
196
Synaptics
SYNA
$4.05B
| $239K | 0.18% |
+3,263
| New | +$266K |
|
|
HIMX
197
Himax Technologies
HIMX
$2.03B
| $237K | 0.18% |
+23,301
| New | +$176K |
|
198
Colgate-Palmolive
CL
$74.8B
| $235K | 0.18% |
3,600
+1,000
| +38% | +$66K |
|
199
Fossil Group
FOSL
$260M
| $235K | 0.18% |
2,500
+2,100
| +525% | +$212K |
|
|
USG
200
DELISTED
Usg
USG
| $234K | 0.18% |
8,511
+6,900
| +428% | +$196K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2014 Portfolio in Review
As of Q3 2014, Seven Eight Capital held 800 positions worth $130M, up 26% from $104M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Seven Eight Capital deployed $34M of net new capital in Q3 2014, opening 284 new positions and adding to 141 existing holdings. Its largest new stake was Sensata Technologies: 29,200 shares worth $1.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Teradata, an estimated $1.08M trimmed.
- Seven Eight Capital's largest Q3 2014 buy was Sensata Technologies: 29,200 shares worth $1.3M.
- Seven Eight Capital added most to Medtronic in Q3 2014, an estimated $1.27M increase.
- Seven Eight Capital's biggest Q3 2014 reduction was Teradata, cutting an estimated $1.08M.
- Seven Eight Capital fully exited Allergan plc in Q3 2014, selling an estimated $1.17M.
- Seven Eight Capital's ten largest holdings make up 10% of its $130M portfolio in Q3 2014.
- Seven Eight Capital opened 284 new positions and closed 294 in Q3 2014.
- Seven Eight Capital's portfolio value rose 26% quarter-over-quarter to $130M.
Based on Seven Eight Capital's 13F filing for Q3 2014, filed 13 Nov 2014.